March 17, 2020March 17, 2020

First Patient Treated in MB-106 CAR T-cell Trial Now Cancer Free, Mustang Says

News

The first patient treated in Mustang Bio‘s Phase 1/2 clinical trial testing its investigational MB-106 therapy for B-cell non-Hodgkin’s lymphoma has achieved a complete response to treatment — meaning that all signs of the ... Read more

June 14, 2018

First Patient Dosed in Phase 2 Trial of eFT508 for Aggressive Non-Hodgkin’s Lymphoma

News

The Phase 1/2 clinical trial evaluating eFT508 for the treatment of relapsed or refractory non-germinal center B-cell (non-GCB) diffuse large B-cell lymphoma (DLBCL) has dosed the first patient in its Phase ... Read more